Tirzepatide explained: what it does, what it costs, and who it fits

What tirzepatide is, in plain terms

Tirzepatide is a once-weekly injection that copies two hormones your gut already makes when you eat: GLP-1 and GIP. Those are incretins, the messengers that tell your brain you are satisfied, tell your pancreas to handle the sugar coming in, and slow the rate your stomach empties.

The branded versions are Mounjaro (approved for type 2 diabetes) and Zepbound (approved for chronic weight management), both made by Eli Lilly and both FDA-approved finished drug products. What we dispense through our program is a compounded preparation, which is a different thing and gets its own section below, because patients deserve the honest version of that sentence.

The reason people care is the effect it has on the part of eating that is hardest to control: the constant background pull toward food. Most patients describe it as quiet. Not willpower, not discipline. The signal got quieter.

Why two receptors instead of one

Semaglutide, the molecule in Ozempic and Wegovy, works on GLP-1 alone. Tirzepatide works on GLP-1 and GIP. That dual action is the whole difference in mechanism, and it shows up in a few places at once.

• Appetite. Both receptors act in the hypothalamus, the part of your brain running hunger and satiety. Hitting two tends to blunt the pull harder than hitting one.
• Gastric emptying. Food sits in your stomach longer, so fullness arrives sooner and at a smaller portion. This is also where most of the nausea comes from.
• Glucose handling. The pancreas releases insulin in better proportion to the meal, and less glucagon comes out. That is why it helps blood sugar even in people without diabetes.
• Fat and energy storage. GIP receptors sit on adipose tissue, and the research here is still evolving. It is a real part of the story and not yet a settled one.

What this does not mean is that tirzepatide is a stronger version of semaglutide in a way we can promise you. Head-to-head comparisons across different trials are not clean apples-to-apples comparisons. We start some patients on one and some on the other depending on history, other medications, tolerance, and cost.

What the first month actually looks like

This is the part people ask about and rarely get a straight answer on, so here is the sequence we run.

Before your first dose: a health intake and metabolic labs. We want A1c, fasting glucose and insulin, a lipid panel, kidney and liver numbers, and thyroid. Some patients add a DEXA body composition scan as a baseline, which tells us how much of what you carry is fat, muscle, and bone, so the scale stops being the only number in the room.

Weeks one and two: the starting dose is 2.5 mg once weekly. That dose is not a treatment dose; it is an introduction, so your gut has time to adjust. Appetite usually drops first. Meals that used to feel normal start to feel like a lot. You may feel a little queasy or unusually full, and that usually fades.

Weeks three and four: side effects have generally settled and we decide whether to move up. Doses go up in steps, about four weeks apart, and the person who stays at a lower dose and eats well is not doing the program wrong.

Every month after that: weight and waist, a check on protein and training, and a look at whether the dose still fits. Some patients repeat a body composition scan every few months so we can see whether the loss is fat or muscle.

The side effects we tell you about before you start

Most of what people feel is in the gut and settles in the first few weeks: nausea, constipation or diarrhea, reflux and belching, early fullness, and a flat or tired feeling. The practical fixes are boring and they work: smaller meals, less fried and fatty food, protein first, stop before you feel stuffed, and drink more water than feels natural, because thirst drops on this medication.

The serious list is shorter but real. Severe abdominal pain that radiates to your back, with or without vomiting, can be pancreatitis. Gallbladder problems show up as pain in the upper right abdomen, especially after fatty meals, and rapid weight loss raises that risk. Severe constipation with no gas passing and a distended belly can mean bowel obstruction. Vomiting and diarrhea that stop you from holding fluids can push your kidneys into trouble. If you take insulin or a sulfonylurea, low glucose is a real risk until those doses are adjusted. Any of those means stop and get seen the same day.

Some people should not be on it at all: anyone with a personal or family history of medullary thyroid carcinoma or MEN2, anyone pregnant or planning pregnancy, anyone with a history of pancreatitis or known gastroparesis. Tell us about anesthesia or surgery coming up, because delayed stomach emptying changes the fasting instructions. And tell us about alcohol: tolerance changes for some patients, and that is worth a conversation rather than a surprise.

The part most clinics skip: muscle

When appetite collapses, people stop eating enough protein, and the body breaks down muscle for fuel along with fat. Studies put lean-mass loss at roughly 25 to 40 percent of total weight lost when patients are not actively protecting it. That matters more than it sounds. Muscle is your largest glucose sink and the tissue that sets your resting metabolism. Lose it, and you come out of the program with a body that burns less than the one you started with, which is exactly the setup for regain.

So we treat the protein and the lifting as part of the prescription, not optional extras. Roughly one gram of protein per pound of goal body weight, resistance training two to three times a week, and a baseline DEXA scan so we can see which tissue is moving. If you want the longer version, we wrote it here: Muscle Loss on GLP-1s.

Compounded vs. branded: what you are actually getting

This is a disclosure, not a footnote, so we will say it plainly.

• The tirzepatide dispensed through our program is a compounded preparation prepared and dispensed by an independently licensed U.S. compounding pharmacy (503A) or FDA-registered outsourcing facility (503B).
• Compounded tirzepatide is not an FDA-approved finished drug product. It is not reviewed by the FDA for safety, efficacy, or manufacturing quality the way an approved drug is.
• It is not the same medication as Mounjaro or Zepbound and is not interchangeable with them.
• Tirzepatide and semaglutide were removed from the FDA drug-shortage list in 2024. Since then, 503A compounding of these molecules is limited to specific clinical-need exceptions, such as a documented allergy or a dose that is not commercially available, as determined by the prescribing clinician.
• The FDA has issued public statements about the risks of compounded GLP-1 products. You can read the FDA statement here.

If your prescriber or insurance can get you the branded product at a price you can live with, that is a good path, and we will tell you so. Our job is the supervision around the medication, not the source of it.

What it costs and how the membership works

Our tirzepatide memberships run $99 to $149 per month, and the tier is set by your prescribed weekly dose. Weekly microdosing at 2.5 mg starts at $99 a month. Higher tiers and individualized titration plans are discussed with your clinician. The membership covers the oversight: provider access, dose titration, and scheduled check-ins. Medication is prescribed only when a clinician determines it is appropriate for you.

Memberships run on a six-month initial commitment, and you may cancel any time after that. We ask for that window because the first six months are where the titration, the habits, and the data actually land. Pricing reflects starting dose tiers, so your final number depends on the dose you end up needing.

Full details, including what is included and the fine print, are on the GLP-1 membership page.

Who may be a good candidate

The clinical criteria most often used: a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, sleep apnea, prediabetes or type 2 diabetes, or joint pain that limits you. Those are a starting point, not a gate. We also want to know what you have already tried, what medications and supplements you take, your thyroid, kidney, and liver numbers, whether you are planning pregnancy, your history with alcohol, and whether there is an eating-disorder history, because that changes how we approach this.

You are probably not a good fit if you want something to take instead of eating well, lifting, and sleeping. Tirzepatide makes those things easier to do; it does not do them for you. And if your weight is already in a healthy range and the goal is a number that a photograph has convinced you is achievable, this is the wrong tool and we will say so at your consult.

How care works at Body Tonic RX

Four steps, same whether you come in or connect from home. You send us your history. You meet a qualified provider, in office or virtually. Your provider writes the plan, including whether medication belongs in it at all. Then you come back monthly so the dose, the protein, the training, and the numbers stay honest.

We are in Westlake Hills and Bee Cave, and we see Texas patients by telehealth. Providers who run this program include Miranda Leal, FNP-C, who reviews our weight-loss content, and our team of nurse practitioners working under the medical direction of an independently licensed supervising physician.